Downregulation of ATG14 by EGR1-MIR152 sensitizes ovarian cancer cells to cisplatin-induced apoptosis by inhibiting cyto-protective autophagy

References

• Peracchio C, Alabiso O, Valente G, Isidoro C. Involvement of autophagy in ovarian cancer: a working hypothesis. J Ovarian Res 2012; 5:22; PMID:22974323; http://dx.doi.org/10.1186/1757-2215-5-22
   PubMed Web of Science ®Google Scholar
• Bookman MA. First-line chemotherapy in epithelial ovarian cancer. Clin Obstet Gynecol 2012; 55:96-113; PMID:22343232; http://dx.doi.org/10.1097/GRF.0b013e31824b45da
   PubMed Web of Science ®Google Scholar
• Galluzzi L, Senovilla L, Vitale I, Michels J, Martins I, Kepp O, Castedo M, Kroemer G. Molecular mechanisms of cisplatin resistance. Oncogene 2012; 31:1869-83; PMID:21892204; http://dx.doi.org/10.1038/onc.2011.384
   PubMed Web of Science ®Google Scholar
• Mathew R, Karantza-Wadsworth V, White E. Role of autophagy in cancer. Nat Rev Cancer 2007; 7:961-7; PMID:17972889; http://dx.doi.org/10.1038/nrc2254
   PubMed Web of Science ®Google Scholar
• Hu YL, Jahangiri A, Delay M, Aghi MK. Tumor cell autophagy as an adaptive response mediating resistance to treatments such as antiangiogenic therapy. Cancer Res 2012; 72:4294-9; PMID:22915758; http://dx.doi.org/10.1158/0008-5472.CAN-12-1076
   PubMed Web of Science ®Google Scholar
• Ventura A, Jacks T. MicroRNAs and cancer: short RNAs go a long way. Cell 2009 136: 586-91; PMID:19239879; http://dx.doi.org/10.1016/j.cell.2009.02.005
   PubMed Web of Science ®Google Scholar
• Hanahan D, Weinberg RA. The hallmarks of cancer. Cell 2000; 100:57-70; PMID:10647931; http://dx.doi.org/10.1016/S0092-8674(00)81683-9
   PubMed Web of Science ®Google Scholar
• Zhai H, Fesler A, Ju J. MicroRNA: a third dimension in autophagy. Cell Cycle 2013 12:246-50; PMID:23255136; http://dx.doi.org/10.4161/cc.23273
   PubMed Web of Science ®Google Scholar
• Kirisako T, Ichimura Y, Okada H, Kabeya Y, Mizushima N, Yoshimori T, Ohsumi M, Takao T, Noda T, Ohsumi Y. The reversible modification regulates the membrane-binding state of Apg8/Aut7 essential for autophagy and the cytoplasm to vacuole targeting pathway. J Cell Biol 2000; 151:263-76; PMID:11038174; http://dx.doi.org/10.1083/jcb.151.2.263
   PubMed Web of Science ®Google Scholar
• Mizushima N, Yoshimori T, Levine B. Methods in mammalian autophagy research. Cell 2010; 140:313-26; PMID:20144757; http://dx.doi.org/10.1016/j.cell.2010.01.028
   PubMed Web of Science ®Google Scholar
• Stanton MJ, Dutta S, Zhang H, Polavaram NS, Leontovich AA, Honscheid P, Sinicrope FA, Tindall DJ, Muders MH, Datta K. Autophagy control by the VEGF-C/NRP-2 axis in cancer and its implication for treatment resistance. Cancer Res 2013; 73:160-71; PMID:23149913; http://dx.doi.org/10.1158/0008-5472.CAN-11-3635
   PubMed Web of Science ®Google Scholar
• Bjorkoy G, Lamark T, Brech A, Outzen H, Perander M, Overvatn A, Stenmark H, Johansen T. p62/SQSTM1 forms protein aggregates degraded by autophagy and has a protective effect on huntingtin-induced cell death. J Cell Biol 2005; 171:603-14; PMID:16286508; http://dx.doi.org/10.1083/jcb.200507002
   PubMed Web of Science ®Google Scholar
• Jung CH, Ro SH, Cao J, Otto NM, Kim DH. mTOR regulation of autophagy. FEBS Lett 2010; 584:1287-95; PMID:20083114; http://dx.doi.org/10.1016/j.febslet.2010.01.017
   PubMed Web of Science ®Google Scholar
• Obara K, Ohsumi Y. Atg14: a key player in orchestrating autophagy. Int J Cell Biol 2011; 2011:713435; PMID:22013444; http://dx.doi.org/10.1155/2011/713435
   PubMedGoogle Scholar
• Fan W, Nassiri A, Zhong Q. Autophagosome targeting and membrane curvature sensing by Barkor/Atg14(L). Proc Natl Acad Sci U S A 2011; 108:7769-74; PMID:21518905; http://dx.doi.org/10.1073/pnas.1016472108
   PubMed Web of Science ®Google Scholar
• Zhu L, Du H, Shi M, Chen Z, Hang J. ATG7 deficiency promote apoptotic death induced by cisplatin in human esophageal squamous cell carcinoma cells. Bull Cancer 2013; 100:15-21; PMID:23823853; http://dx.doi.org/10.1684/bdc.2013.1749
   PubMedGoogle Scholar
• Ahmed MM. Regulation of radiation-induced apoptosis by early growth response-1 gene in solid tumors. Curr Cancer Drug Targets 2004; 4:43-52; PMID:14965266; http://dx.doi.org/10.2174/1568009043481704
   PubMed Web of Science ®Google Scholar
• Welsh JB, Zarrinkar PP, Sapinoso LM, Kern SG, Behling CA, Monk BJ, Lockhart DJ, Burger RA, Hampton GM. Analysis of gene expression profiles in normal and neoplastic ovarian tissue samples identifies candidate molecular markers of epithelial ovarian cancer. Proc Natl Acad Sci U S A 2001; 98:1176-81; PMID:11158614; http://dx.doi.org/10.1073/pnas.98.3.1176
   PubMed Web of Science ®Google Scholar
• Yoshihara K, Tajima A, Komata D, Yamamoto T, Kodama S, Fujiwara H, Suzuki M, Onishi Y, Hatae M, Sueyoshi K., et al. Gene expression profiling of advanced-stage serous ovarian cancers distinguishes novel subclasses and implicates ZEB2 in tumor progression and prognosis. Cancer Sci 2009; 100:1421-8; PMID:19486012; http://dx.doi.org/10.1111/j.1349-7006.2009.01204.x
   PubMedGoogle Scholar
• Yan BX, Ma JX, Zhang J, Guo Y, Riedel H, Mueller MD, Remick SC, Yu JJ. PSP94 contributes to chemoresistance and its peptide derivative PCK3145 represses tumor growth in ovarian cancer. Oncogene 2014; 33:5288-94; PMID:24186202; http://dx.doi.org/10.1038/onc.2013.466
   PubMedGoogle Scholar
• Reed E, Yu JJ, Davies A, Gannon J, Armentrout SL. Clear cell tumors have higher mRNA levels of ERCC1 and XPB than other histological types of epithelial ovarian cancer. Clin Cancer Res 2003 9:5299-305; PMID:14614013
   PubMed Web of Science ®Google Scholar
• Muggia F Platinum compounds 30 years after the introduction of cisplatin: implications for the treatment of ovarian cancer. Gynecol Oncol 2009 112:275-81; PMID:18977023; http://dx.doi.org/10.1016/j.ygyno.2008.09.034
   PubMed Web of Science ®Google Scholar
• Xiang Y, Ma N, Wang D, Zhang Y, Zhou J, Wu G, Zhao R, Huang H, Wang X, Qiao Y., et al. MiR-152 and miR-185 co-contribute to ovarian cancer cells cisplatin sensitivity by targeting DNMT1 directly: a novel epigenetic therapy independent of decitabine. Oncogene 2014; 33:378-86; PMID:23318422; http://dx.doi.org/10.1038/onc.2012.575
   PubMedGoogle Scholar
• Ali AY, Farrand L, Kim JY, Byun S, Suh JY, Lee HJ, Tsang BK Molecular determinants of ovarian cancer chemoresistance: new insights into an old conundrum. Ann N Y Acad Sci 2012; 1271:58-67; PMID:23050965; http://dx.doi.org/10.1111/j.1749-6632.2012.06734.x
   PubMed Web of Science ®Google Scholar
• Yu H, Su J, Xu Y, Kang J, Li H, Zhang L, Yi H, Xiang X, Liu F, Sun L p62/SQSTM1 involved in cisplatin resistance in human ovarian cancer cells by clearing ubiquitinated proteins. Eur J Cancer 2011; 47:1585-94; PMID:21371883; http://dx.doi.org/10.1016/j.ejca.2011.01.019
   PubMed Web of Science ®Google Scholar
• Zhang Y, Cheng Y, Ren X, Zhang L, Yap KL, Wu H, Patel R, Liu D, Qin ZH, Shih IM., et al. NAC1 modulates sensitivity of ovarian cancer cells to cisplatin by altering the HMGB1-mediated autophagic response. Oncogene 2012; 31:1055-64; PMID:21743489; http://dx.doi.org/10.1038/onc.2011.290
   PubMed Web of Science ®Google Scholar
• Alexander A, Cai SL, Kim J, Nanez A, Sahin M, MacLean KH, Inoki K, Guan KL, Shen J, Person MD., et al. ATM signals to TSC2 in the cytoplasm to regulate mTORC1 in response to ROS. Proc Natl Acad Sci U S A 2010; 107:4153-8; PMID:20160076; http://dx.doi.org/10.1073/pnas.0913860107
   PubMed Web of Science ®Google Scholar
• Gaur S, Chen L, Yang L, Wu X, Un F, Yen Y. Inhibitors of mTOR overcome drug resistance from topoisomerase II inhibitors in solid tumors. Cancer Lett 2011; 311:20-8; PMID:21764510; http://dx.doi.org/10.1016/j.canlet.2011.06.005
   PubMed Web of Science ®Google Scholar
• Santiskulvong C, Konecny GE, Fekete M, Chen KY, Karam A, Mulholland D, Eng C, Wu H, Song M, Dorigo O. Dual targeting of phosphoinositide 3-kinase and mammalian target of rapamycin using NVP-BEZ235 as a novel therapeutic approach in human ovarian carcinoma. Clin Cancer Res 2011; 17:2373-84; PMID:21372221; http://dx.doi.org/10.1158/1078-0432.CCR-10-2289
   PubMed Web of Science ®Google Scholar
• Woo HH, Laszlo CF, Greco S, Chambers SK. Regulation of colony stimulating factor-1 expression and ovarian cancer cell behavior in vitro by miR-128 and miR-152. Mol Cancer 2012; 11:58; PMID:22909061; http://dx.doi.org/10.1186/1476-4598-11-58
   PubMed Web of Science ®Google Scholar
• Xu Q, Jiang Y, Yin Y, Li Q, He J, Jing Y, Qi YT, Xu Q, Li W, Lu B., et al. A regulatory circuit of miR-148a/152 and DNMT1 in modulating cell transformation and tumor angiogenesis through IGF-IR and IRS1. J Mol Cell Biol 2013; 5:3-13; PMID:22935141; http://dx.doi.org/10.1093/jmcb/mjs049
   PubMed Web of Science ®Google Scholar
• Mancini M, Saintigny G, Mahe C, Annicchiarico-Petruzzelli M, Melino G, Candi E. MicroRNA-152 and -181a participate in human dermal fibroblasts senescence acting on cell adhesion and remodeling of the extra-cellular matrix. Aging (Albany NY) 2012; 4:843-53; PMID:23238588
   PubMedGoogle Scholar
• Wu Y, Huang A, Li T, Su X, Ding H, Li H, Qin X, Hou L, Zhao Q, Ge X., et al. MiR-152 reduces human umbilical vein endothelial cell proliferation and migration by targeting ADAM17. FEBS Lett 2014; 588:2063-9; PMID:24813629; http://dx.doi.org/10.1016/j.febslet.2014.04.037
   PubMed Web of Science ®Google Scholar
• Fogel AI, Dlouhy BJ, Wang C, Ryu SW, Neutzner A, Hasson SA, Sideris DP, Abeliovich H, Youle RJ. Role of membrane association and Atg14-dependent phosphorylation in beclin-1-mediated autophagy. Mol Cell Biol 2013; 33:3675-88; PMID:23878393; http://dx.doi.org/10.1128/MCB.00079-13
   PubMed Web of Science ®Google Scholar
• Xiong X, Tao R, DePinho RA, Dong XC. The autophagy-related gene 14 (Atg14) is regulated by forkhead box O transcription factors and circadian rhythms and plays a critical role in hepatic autophagy and lipid metabolism. J Biol Chem 2012; 287:39107-14; PMID:22992773; http://dx.doi.org/10.1074/jbc.M112.412569
   PubMed Web of Science ®Google Scholar
• Calogero A, Arcella A, De GG, Porcellini A, Mercola D, Liu C, Lombari V, Zani M, Giannini G, Gagliardi FM., et al. The early growth response gene EGR-1 behaves as a suppressor gene that is down-regulated independent of ARF/Mdm2 but not p53 alterations in fresh human gliomas. Clin Cancer Res 2001; 7:2788-96; PMID:11555594
   PubMed Web of Science ®Google Scholar
• McDoniels-Silvers AL, Nimri CF, Stoner GD, Lubet RA, You M. Differential gene expression in human lung adenocarcinomas and squamous cell carcinomas. Clin Cancer Res 2002; 8:1127-38; PMID:11948124
   PubMed Web of Science ®Google Scholar
• Gitenay D, Baron VT. Is EGR1 a potential target for prostate cancer therapy? Future Oncol 2009 5:993-1003; PMID:19792968; http://dx.doi.org/10.2217/fon.09.67
   PubMed Web of Science ®Google Scholar
• Wu MY, Liang YR, Wu XY, Zhuang CX. Relationship between Egr-1 gene expression and apoptosis in esophageal carcinoma and precancerous lesions. World J Gastroenterol 2002; 8:971-5; PMID:12439908
   PubMedGoogle Scholar
• Das A, Chendil D, Dey S, Mohiuddin M, Mohiuddin M, Milbrandt J, Rangnekar VM, Ahmed MM. Ionizing radiation down-regulates p53 protein in primary Egr-1-/- mouse embryonic fibroblast cells causing enhanced resistance to apoptosis. J Biol Chem 2001; 276:3279-86; PMID:11035041; http://dx.doi.org/10.1074/jbc.M008454200
   PubMedGoogle Scholar
• Deloia JA, Bhagwat NR, Darcy KM, Strange M, Tian C, Nuttall K, Krivak TC, Niedernhofer LJ. Comparison of ERCC1/XPF genetic variation, mRNA and protein levels in women with advanced stage ovarian cancer treated with intraperitoneal platinum. Gynecol Oncol 2012; 126:448-54; PMID:22609620; http://dx.doi.org/10.1016/j.ygyno.2012.05.006
   PubMedGoogle Scholar
• Weberpals J, Garbuio K, O'Brien A, Clark-Knowles K, Doucette S, Antoniouk O, Goss G, Dimitroulakos J. The DNA repair proteins BRCA1 and ERCC1 as predictive markers in sporadic ovarian cancer. Int J Cancer 2009; 124:806-15; PMID:19035454; http://dx.doi.org/10.1002/ijc.23987
   PubMed Web of Science ®Google Scholar
• Solomon VR, Lee H. Chloroquine and its analogs: a new promise of an old drug for effective and safe cancer therapies. Eur J Pharmacol 2009; 625:220-33; PMID:19836374; http://dx.doi.org/10.1016/j.ejphar.2009.06.063
   PubMed Web of Science ®Google Scholar
• Bristol ML, Emery SM, Maycotte P, Thorburn A, Chakradeo S, Gewirtz DA. Autophagy inhibition for chemosensitization and radiosensitization in cancer: do the preclinical data support this therapeutic strategy? J Pharmacol Exp Ther 2013; 344:544-52; PMID:23291713; http://dx.doi.org/10.1124/jpet.112.199802
   PubMed Web of Science ®Google Scholar
• Kimura T, Takabatake Y, Takahashi A, Isaka Y. Chloroquine in cancer therapy: a double-edged sword of autophagy. Cancer Res 2013; 73:3-7; PMID:23288916; http://dx.doi.org/10.1158/0008-5472.CAN-12-2464
   PubMed Web of Science ®Google Scholar